PGLYRP1 and breast carcinoma: These findings confirmed our previous data, which suggested that the risk of myocardial injury by the first exposure with DOX in breast cancer may be predicted by the circulating levels of neutrophil-associated proteins PGLYRP1, CAMP, MMP9 and CEACAM8.